Product Details
Fraxiparine
Nadroparin Calcium9500 IU/mL
Solution for Injection
0.6-mL Prefilled Syringe Pack
DIN/PIN/NPN
09853952
Manufacturer
Aspen Pharma Trading Limited
Formulary Listing Date
1999-04-15
Unit Price
9.0580
Amount MOH Pays
9.0580
Coverage Status
Limited Use Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
Interchangeable Products
NOLU Clinical Criteria
| LU Code | Auth. Period | Clinical Criteria |
|---|---|---|
| 186 | 1 year | For acute treatment of deep venous thrombosis (DVT), for a maximum of three weeks; |
| 187 | 1 year | For DVT in pregnant or lactating females; |
| 188 | 1 year | For DVT in patients whom treatment with warfarin is not tolerated, or contraindicated; |
| 189 | 1 year | For DVT in patients who have failed treatment with warfarin. |
EAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Anticoagulants | Nadroparin
For the post-operative prophylaxis of venous thromboembolism following abdominal or pelvic surgery for cancer in patients who do not have a history of or risk factors for heparin-induced thrombocytopenia. Standard Approval Duration: Maximum of 30 days EAP Drug Request Form: |